Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial

Background and purpose: concomitant radio-chemotherapy is the gold standard treatment for unresectable head and neck carcinomas Placement of prophylactic gastrostomy has been proposed to provide adequate nutution during the therapeutic sequence The objectives of this study were to assess the impact of prophylactic gastrostomy on the 6-month quality of life, and to determine the factors related to this quality of life Materials and methods Design. randomized. controlled, open study (systematic percutaneous gastrostomy versus no systematic gastrostomy) Patients squamous cell head and neck carcinoma (stages III and IV. UICC 1997) Setting oncological departments of French university teaching hospitals Treatment optimal concomitant radio-chemotherapy. Evaluations. T0 baseline evaluation, T1 during the treatment. T2 end of the treatment, and T3 6-month post-inclusion Primary endpoint 6-month quality of life (Qol) assessed using SF36. EORTC QLQ-C30. EORTC QLQ H&NN35 questionnaires Results The Qol changes from baseline included a decline (T1 arid T2) followed by an improvement (T3) Qol at 6 months was significantly higher in the group receiving systematic prophylactic gastiostomy (p= 10(3)) Higher initial BMI arid lower initial Karnofsky index were significant factors related to a higher 6-month Qol Conclusions The study results suggest that prophylactic gastiostomy improves post-treatment quality of life for unresectable head and neck cancer patients, after adjusting for other potential predictive quality of life factors (C) 2009 Elsevier Ireland Ltd All rights reserved Radiotherapy anti Oncology 93 (2009) 503-509